Relationship Between Blood Eosinophils and Systemic Corticosteroid Therapy in COPD Exacerbation

Relationship Between Blood Eosinophils and Systemic Corticosteroid Therapy in COPD Exacerbation

Yaya Gong, Hongyan Sun Department of Respiratory Medicine, Anhui No.2 Provincial People’s Hospital, Hefei, People’s Republic of ChinaCorrespondence: Hongyan Sun, Tel +86 13856934496, Email sunhyanah@126.comPurpose: To assess the relationship between the duration of systemic corticosteroid therapy an...

Full description

Bibliographic Details
Main Authors:	Gong Y, Sun H
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-09-01
Series:	International Journal of General Medicine
Subjects:	chronic obstructive pulmonary disease exacerbation corticosteroid eosinophils.
Online Access:	https://www.dovepress.com/relationship-between-blood-eosinophils-and-systemic-corticosteroid-the-peer-reviewed-fulltext-article-IJGM

Similar Items

Stability of Blood Eosinophils in COPD with Multiple Acute Exacerbations Within 1 Year and Its Relationship with Prognosis
by: Gong Y, et al.
Published: (2022-12-01)

Blood eosinophil count in patients with COPD on inhaled corticosteroids in comparison with healthy smoker and nonsmoker controls
by: Noha Othman Ahmed, et al.
Published: (2021-01-01)

Blood and sputum eosinophilia in COPD exacerbation
by: Laila Ashour Helala, et al.
Published: (2022-09-01)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
by: Vestbo J, et al.
Published: (2019-04-01)

Exacerbation and Cardiovascular Events in Eosinophilic Chronic Obstructive Pulmonary Disease
by: Mami Orimo, et al.
Published: (2023-04-01)

Clinical implications of blood eosinophil count in patients with non-asthma–COPD overlap syndrome COPD
by: Song JH, et al.
Published: (2017-08-01)

Comparison of the Clinical Outcomes Between Nebulized and Systemic Corticosteroids in the Treatment of Acute Exacerbation of COPD in China (CONTAIN Study): A Post Hoc Analysis
by: Chen Y, et al.
Published: (2020-09-01)

Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis
by: Timothy H. Harries, et al.
Published: (2020-01-01)

The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
by: Choi J, et al.
Published: (2019-05-01)

A systematic review and integrated analysis of biologics that target Type 2 inflammation to treat COPD with increased peripheral blood eosinophils
by: Hiroshi Ohnishi, et al.
Published: (2022-06-01)

Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis
by: Wang Chun Kwok, et al.
Published: (2023-06-01)

Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease
by: Pradeesh Sivapalan, et al.
Published: (2021-02-01)

Association Between Blood Eosinophils and Mortality in Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study
by: Yang J, et al.
Published: (2021-02-01)

Inhaled Corticosteroid Use Among COPD Patients in Primary Care in Spain
by: Miravitlles M, et al.
Published: (2022-01-01)

Blood eosinophils and C-reactive protein as prognostic factors in severe chronic obstructive pulmonary disease exacerbations
by: Hamed A. Hafiz, et al.
Published: (2020-01-01)

Low Eosinophil Phenotype Predicts Noninvasive Mechanical Ventilation Use in Patients with Hospitalized Exacerbations of COPD [Corrigendum]
by: Wei T, et al.
Published: (2022-03-01)

Treatment of coccidioidomycosis-associated eosinophilic pneumonia with corticosteroids
by: Raz Y, et al.
Published: (2012-03-01)

Evaluation of exacerbations and blood eosinophils in UK and US COPD populations
by: Claus F. Vogelmeier, et al.
Published: (2019-08-01)

Differences in the lipid metabolism profile and clinical characteristics between eosinophilic and non-eosinophilic acute exacerbation of chronic obstructive pulmonary disease
by: Yating Wang, et al.
Published: (2023-07-01)

Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis
by: Cheng SL
Published: (2018-09-01)

COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?
by: Osman Savran, et al.
Published: (2021-02-01)

Neutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypes
by: Aksoy E, et al.
Published: (2018-09-01)

Predictors of Influenza PCR Positivity in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
by: Chen CYJ, et al.
Published: (2022-01-01)

Blood eosinophil count as a prognostic biomarker in COPD
by: Oh YM, et al.
Published: (2018-10-01)

The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD
by: Sun T, et al.
Published: (2020-08-01)

Treatment of COPD exacerbations: antibiotics
by: R. Wilson
Published: (2005-09-01)

Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts
by: Cheng SL, et al.
Published: (2016-09-01)

Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations
by: Lin CM, et al.
Published: (2020-02-01)

Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects
by: Dave Singh
Published: (2020-07-01)

Compare the Effect of Inhaled Corticosteroids and Systemic Corticosteroids on Sputum Microbiome of AECOPD
by: Nan Ma, et al.
Published: (2021-02-01)

Nebulized corticosteroids in the management of acute exacerbation of COPD
by: Gaude G, et al.
Published: (2010-01-01)

Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy
by: Chen S, et al.
Published: (2022-09-01)

Eicosanoids and Eosinophilic Inflammation of Airways in Stable COPD
by: Celejewska-Wójcik N, et al.
Published: (2021-05-01)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
by: Siddiqui SH, et al.
Published: (2018-11-01)

Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation
by: Jo YS, et al.
Published: (2017-12-01)

Characteristics of 12-Month Readmission for Hospitalized Patients with COPD: A Propensity Score Matched Analysis of Prospective Multicenter Study
by: Xu T, et al.
Published: (2022-09-01)

Blood Eosinophils and Clinical Outcomes in Inpatients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study
by: Pu J, et al.
Published: (2023-02-01)

Prediction value of neutrophil and eosinophil count at risk of COPD exacerbation
by: Tzu-Tao Chen, et al.
Published: (2023-12-01)

Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts
by: Müllerová H, et al.
Published: (2019-03-01)

Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD
by: Zysman M, et al.
Published: (2017-06-01)